
Accelerate with confidence
Schedule a call to learn how IPST can deliver your preclinical research on-time and on-budget. Our 24 years of experience will strengthen your drug development pipeline. Analysis & guidance included — always.
Dedicated to scientific excellence since 1999, IPS Therapeutique (IPST) is a contract research organization (CRO) specialized in the preclinical evaluation of the efficacy and safety of new drugs using validated and highly predictive models. IPST’s science has been featured in more than 200 peer-reviewed articles since 2000.
Reduce the costs of early drug development
IPST will shorten the time spent with a risky molecule and lower the costs of the Discovery and Lead Optimization phase of your project.


The benefits of inhalation models – A conversation with IPST’s Dan Salvail
by Dany Salvail Ph.D., Vice-President.
Published on May 1, 2022
Read moreFemale rats respond better to Sildenafil treatment in SuHx-induced PAH model
by Charles-E. Laurent Ph.D., Director of In-Vivo Pharmacology
Published on May 1, 2020
Read more